163 related articles for article (PubMed ID: 37089447)
1. CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport.
Tian C; Yuan H; Lu Y; He H; Li Q; Li S; Yang J; Wang M; Xu R; Liu Q; Xiang M
Oncoimmunology; 2023; 12(1):2204015. PubMed ID: 37089447
[TBL] [Abstract][Full Text] [Related]
2. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway.
Li Q; He J; Li S; Tian C; Yang J; Yuan H; Lu Y; Fagone P; Nicoletti F; Xiang M
Clin Immunol; 2023 Mar; 248():109217. PubMed ID: 36581220
[TBL] [Abstract][Full Text] [Related]
3. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.
Hara H; Ishihara C; Takeuchi A; Xue L; Morris SW; Penninger JM; Yoshida H; Saito T
J Immunol; 2008 Jul; 181(2):918-30. PubMed ID: 18606643
[TBL] [Abstract][Full Text] [Related]
4. Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9.
Holliday MJ; Ferrao R; de Leon Boenig G; Estevez A; Helgason E; Rohou A; Dueber EC; Fairbrother WJ
J Biol Chem; 2018 Oct; 293(43):16803-16817. PubMed ID: 30206119
[TBL] [Abstract][Full Text] [Related]
5. An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells.
Yasukawa S; Miyazaki Y; Yoshii C; Nakaya M; Ozaki N; Toda S; Kuroda E; Ishibashi K; Yasuda T; Natsuaki Y; Mi-ichi F; Iizasa E; Nakahara T; Yamazaki M; Kabashima K; Iwakura Y; Takai T; Saito T; Kurosaki T; Malissen B; Ohno N; Furue M; Yoshida H; Hara H
Nat Commun; 2014 May; 5():3755. PubMed ID: 24806599
[TBL] [Abstract][Full Text] [Related]
6. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
7. Differential use of CARD9 by dectin-1 in macrophages and dendritic cells.
Goodridge HS; Shimada T; Wolf AJ; Hsu YM; Becker CA; Lin X; Underhill DM
J Immunol; 2009 Jan; 182(2):1146-54. PubMed ID: 19124758
[TBL] [Abstract][Full Text] [Related]
8. In vitro reconstitution of interactions in the CARD9 signalosome.
Park JH; Choi JY; Mustafa MF; Park HH
Mol Med Rep; 2017 Oct; 16(4):3910-3916. PubMed ID: 28765954
[TBL] [Abstract][Full Text] [Related]
9. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.
LeibundGut-Landmann S; Gross O; Robinson MJ; Osorio F; Slack EC; Tsoni SV; Schweighoffer E; Tybulewicz V; Brown GD; Ruland J; Reis e Sousa C
Nat Immunol; 2007 Jun; 8(6):630-8. PubMed ID: 17450144
[TBL] [Abstract][Full Text] [Related]
10. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
[TBL] [Abstract][Full Text] [Related]
11. SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.
Li Q; Liu M; Sun Y; Jin T; Zhu P; Wan X; Hou Y; Tu G
J Exp Clin Cancer Res; 2021 May; 40(1):168. PubMed ID: 33990217
[TBL] [Abstract][Full Text] [Related]
12. Role of CARD9 in Cell- and Organ-Specific Immune Responses in Various Infections.
Lee JS; Kim C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473845
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells.
Xu S; Huo J; Lee KG; Kurosaki T; Lam KP
J Biol Chem; 2009 Mar; 284(11):7038-46. PubMed ID: 19136564
[TBL] [Abstract][Full Text] [Related]
14. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation.
Zhao XQ; Zhu LL; Chang Q; Jiang C; You Y; Luo T; Jia XM; Lin X
J Biol Chem; 2014 Oct; 289(43):30052-62. PubMed ID: 25202022
[TBL] [Abstract][Full Text] [Related]
15. CARD9 inhibits mitochondria-dependent apoptosis of cardiomyocytes under oxidative stress via interacting with Apaf-1.
Li Y; Liang P; Jiang B; Tang Y; Lv Q; Hao H; Liu Z; Xiao X
Free Radic Biol Med; 2019 Sep; 141():172-181. PubMed ID: 31212066
[TBL] [Abstract][Full Text] [Related]
16. CARD9 signaling in the innate immune response.
Ruland J
Ann N Y Acad Sci; 2008 Nov; 1143():35-44. PubMed ID: 19076343
[TBL] [Abstract][Full Text] [Related]
17.
Sun L; Zhang S; Wan Z; Li R; Yu J
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33649049
[No Abstract] [Full Text] [Related]
18. CARD9 mediates dendritic cell-induced development of Lyn deficiency-associated autoimmune and inflammatory diseases.
Ma J; Abram CL; Hu Y; Lowell CA
Sci Signal; 2019 Oct; 12(602):. PubMed ID: 31594855
[TBL] [Abstract][Full Text] [Related]
19. Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity.
Uematsu T; Iizasa E; Kobayashi N; Yoshida H; Hara H
Sci Rep; 2015 Dec; 5():17577. PubMed ID: 26627732
[TBL] [Abstract][Full Text] [Related]
20. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
